Envveno Medical Quick Ratio (NVNO) starting from the third quarter 2026 to third quarter 2025, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
Envveno Medical Corporation  (NASDAQ: NVNO)

Envveno Medical's Quick Ratio

NVNO's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


In the wake of the increase in Current Liabilities in the third quarter 2026, Quick Ratio fell to 7.13 below Envveno Medical Corporation average.

Within Medical Equipment & Supplies industry 9 other companies have achieved higher Quick Ratio than Envveno Medical in third quarter 2026. While Quick Ratio total ranking in the third quarter 2026 has deteriorated compared to the prior quarter from 341 to 406.

Explain Quick Ratio?
How much Cash & cash equivalents NVNO´s has?
What are NVNO´s Current Liabilities?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

NVNO Quick Ratio (Sep 30 2026)
Q3		 (Jun 30 2026)
Q2		 (Mar 31 2026)
Q1		 (Dec 31 2025)
Q4		 (Sep 30 2025)
Q3
Y / Y Current Liabilities Change 7.88 % -37.41 % 29.02 % 1.29 % 7.67 %
Y / Y Cash & cash equivalent Change -40.32 % -38.86 % -35.98 % -34.62 % -36.02 %
Quick Ratio MRQ 7.13 11.39 11.63 13.3 12.9
NVNO's Total Ranking # 406 # 341 # 241 # 211 #
Seq. Current Liabilities Change 37.2 % -11.95 % 0.99 % -11.58 % -20.4 %
Seq. Cash & cash equivalent Change -14.03 % -13.81 % -11.63 % -8.85 % -11.92 %



Quick Ratio third quarter 2026 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 10
Healthcare Sector # 139
Overall Market # 406


Quick Ratio Statistics
High Average Low
135.53 17.82 0.01
(Sep 30 2021)  




Financial Statements
Envveno Medical's Current Liabilities $ 3 Millions Visit NVNO's Balance sheet
Envveno Medical's Cash & cash equivalent $ 18 Millions Visit NVNO's Balance sheet
Source of NVNO's Sales Visit NVNO's Sales by Geography


Cumulative Envveno Medical's Quick Ratio

NVNO's Quick Ratio for the trailling 12 Months

NVNO Quick Ratio

 (Sep 30 2026)
12 Months		 (Jun 30 2026)
12 Months		 (Mar 31 2026)
12 Months		 (Dec 31 2025)
12 Months		 (Sep 30 2025)
12 Months
Y / Y Current Liabilities TTM Growth -4.69 % -4.98 % 26.04 % 22.54 % 35.23 %
Y / Y Cash & cash equivalent TTM Growth -37.17 % -36.25 % -29.67 % -23.22 % -16.18 %
Quick Ratio TTM 10.65 12.35 12.32 14.49 16.16
Total Ranking TTM # 1339 # 1434 # 1210 # 449 # 374
Seq. Current Liabilities TTM Growth 2.21 % -11.65 % 5.24 % 0.29 % 1.9 %
Seq. Cash & cash equivalent TTM Growth -11.82 % -11.45 % -10.52 % -10.08 % -10.52 %

Quick ratio ranking by company, industry and sector >> Back to NVNO Financial Strength Comparisons >> Go to Compare NVNO Quick Ratio to its Competitors

On the trailing twelve months basis Due to growth in Current Liabilities in the Q3 2026 to $2.59 millions, cumulative Quick Ratio decreased to 10.65 above the NVNO average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 200 other companies have achieved higher Quick Ratio than Envveno Medical. While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the second quarter 2026 from 2616 to 3929.

Explain Quick Ratio?
How much Cash & cash equivalents NVNO´s has?
What are NVNO´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 201
Healthcare Sector # 889
Within the Market #


trailing twelve months Quick Ratio Statistics
High Average Low
38.24 6.59 0.67
(Mar 31 2022)   (Jun 30 2018)




Companies with similar Quick Ratio in the quarter ending Sep 30 2026, within Medical Equipment & Supplies Industry Quick RatioSep 30 2026 MRQ Cash & cash equivalentSep 30 2026 MRQ Current Liabilities
Bone Biologics Corporation  12.66 $ 6.088  Millions$ 0.481  Millions
Lemaitre Vascular Inc   11.26 $ 389.721  Millions$ 34.620  Millions
Mobia Medical Inc   10.63 $ 160.692  Millions$ 15.115  Millions
Axogen inc   9.55 $ 348.068  Millions$ 36.456  Millions
Envveno Medical Corporation  7.13 $ 18.472  Millions$ 2.589  Millions
Ceribell Inc   6.51 $ 117.467  Millions$ 18.034  Millions
Iradimed Corporation  6.13 $ 63.288  Millions$ 10.323  Millions
Clearpoint Neuro Inc   4.68 $ 46.184  Millions$ 9.869  Millions
Cvrx inc   4.67 $ 58.746  Millions$ 12.583  Millions
Dexcom Inc   4.25 $ 964.800  Millions$ 227.000  Millions
Sight Sciences Inc   3.84 $ 77.402  Millions$ 20.137  Millions
Profound Medical Corp   3.41 $ 33.343  Millions$ 9.771  Millions
Rxsight Inc   3.40 $ 254.683  Millions$ 74.952  Millions
Omada Health Inc   3.23 $ 243.151  Millions$ 75.379  Millions
Transmedics Group Inc   3.22 $ 492.962  Millions$ 152.857  Millions
Procept Biorobotics Corporation  3.10 $ 218.369  Millions$ 70.353  Millions
Outset Medical Inc   3.07 $ 136.627  Millions$ 44.453  Millions
Sharps Technology Inc   2.82 $ 7.478  Millions$ 2.650  Millions
Edwards Lifesciences Corporation  2.81 $ 4,683.700  Millions$ 1,664.300  Millions
Mimedx Group Inc   2.81 $ 120.791  Millions$ 43.031  Millions
Pulse Biosciences Inc   2.74 $ 36.725  Millions$ 13.395  Millions
Staar Surgical Co  2.73 $ 206.414  Millions$ 75.541  Millions
Medinotec Inc   2.68 $ 2.584  Millions$ 0.963  Millions
Glaukos Corp  2.66 $ 337.478  Millions$ 126.726  Millions
Pulmonx Corporation  2.57 $ 53.245  Millions$ 20.739  Millions
Beta Bionics Inc   2.48 $ 81.551  Millions$ 32.836  Millions
Irhythm Holdings Inc   2.46 $ 560.719  Millions$ 228.025  Millions
Apyx Medical Corp  2.37 $ 25.777  Millions$ 10.870  Millions
Atricure Inc   2.23 $ 187.031  Millions$ 83.972  Millions
Inspire Medical Systems inc   1.96 $ 190.803  Millions$ 97.438  Millions

Date modified: 2026-10-30T17:01:14+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.